A Systematic Review of Vinorelbine for the Treatment of Breast Cancer
Author:
Affiliation:
1. Department of Oncology; Shanghai Renji Hospital; Shanghai Jiaotong University School of Medicine; China
2. Suzhou Kowlong Hospital; Shanghai Jiaotong University School of Medicine; China
Publisher
Hindawi Limited
Subject
Oncology,Surgery,Internal Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/tbj.12071/fullpdf
Reference34 articles.
1. Vinorelbine-a clinical review;Gregory;Br J Cancer,2000
2. A randomized phase II trial of two different schedules of mitomycin C and vinorelbine in pretreated breast cancer;Colleoni;Oncology,1997
3. Vinorelbine, methotrexate and fluorouracil (VMF) as first-line therapy in metastatic breast cancer: a randomized phase II trial;Elomaa;Ann Oncol,2003
4. A randomized multicenter study of optimal circadian time of vinorelbine combined with chronomodulated 5-fluorouracil in pretreated metastatic breast cancer patients: EORTC trial 05971;Coudert;Chronobiol Int,2008
5. Alternating intravenous and oral vinorelbine plus epirubicin with pegfilgrastim as neoadjuvant treatment of locally advanced breast cancer;Livi;Anticancer Drugs,2006
Cited by 29 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Vinorelbine Improves the Efficacy of Sorafenib against Hepatocellular Carcinoma: A Promising Therapeutic Approach;International Journal of Molecular Sciences;2024-01-26
2. Pemetrexed plus vinorelbine versus vinorelbine monotherapy in patients with metastatic breast cancer (KCSG-BR15-17): A randomized, open-label, multicenter, phase II trial;European Journal of Cancer;2024-01
3. Everolimus Acts in Synergy with Vinorelbine to Suppress the Growth of Hepatocellular Carcinoma;International Journal of Molecular Sciences;2023-12-19
4. Vinorelbine thiotepa in metastatic breast cancer: a large real-life retrospective study;Acta Oncologica;2023-09-26
5. Nanotechnology Approaches for Prevention and Treatment of Chemotherapy‐Induced Neurotoxicity, Neuropathy, and Cardiomyopathy in Breast and Ovarian Cancer Survivors;Small;2023-04-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3